Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

Published:2006-03-23 Issue:4 Volume:58 Page:527-531
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Feliu J.,Martín G.,Castro J.,Sundlov A.,Rodriguez-Jaráiz A.,Casado E.,Lomas M.,Madroñal C.,Galán A.,Belda C.,Gonzalez-Barón M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0198-5.pdf

Reference29 articles.

1. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA et al (1993) Polychemotherapy in advanced non small lung cancer: a meta-analysis. Lancet 342:19–21

2. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899–909

3. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O´Rourke M (2000) Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18:2095–2103

4. Shepherd FA, Fossella FV, Lynch T, Armand JP, Rigas JR, Kris MG (2001) Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials. Semin Oncol 28(Suppl 2):4–9

5. Fossella FV, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kankel E et al (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016–3024

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting anticancer synergistic drug combinations based on multi-task learning;BMC Bioinformatics;2023-11-27

2. Chemotherapy-Induced Peripheral Neuropathy;Chemotherapy-Induced Neuropathic Pain;2012-07-06

3. Second and third line treatment in non-small cell lung cancer;Critical Reviews in Oncology/Hematology;2009-08

4. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells;Carcinogenesis;2008-05-29

5. Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer;Lung Cancer;2008-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3